Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allogeneic Sibling and Unrelated Donor Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Busulfan, Etoposide and Cyclophosphamide

NCT00186342 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT00186342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00186342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allogeneic Sibling and Unrelated Donor Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Busulfan, Etoposide and Cyclophosphamide
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Completed
Start date
September 30, 1992
Completion date
January 31, 2009
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute disease, blood and marrow transplant (bmt), leukemia, leukemia, myeloid, chronic, myelodysplastic syndromes, myelodysplastic syndromes (mds), myeloproliferative disorders